THE VERESCA LEADERSHIP TEAM
®
Roberto Fagnani, PhD
Chairman & CEO
-
US/EU Venture Funds
-
CoFounder
-
Eli Lilly & Company/Hybritech
-
-
University of California
-
US National Cancer Institute
​
PhD, Pharmacology: University of Milano, Italy
Partha S. Ray, MD
Chairman
Scientific Advisory Board
-
HCG - Oncology, India
-
​Professor and Head of Surgical Oncology
-
-
University of Illinois College of Medicine, Urbana-Champaign, Illinois
- ​​Assistant Professor of Surgery
-
John Wayne Cancer Institute​
-
Surgical Oncology Fellowship​​
-
​
MD: Drexel University College of Medicine
Gerry Burke
VP Operations
-
Synergy Flow Ltd.
-
Managing Director​
-
-
Biocept Laboratories Europe Ltd.
-
Managing Director​
-
-
Boston Scientific, Letterkenny
-
Plant Manager
-
-
IVT Europe Ltd.
-
Mgr, Intnl Regulatory Affairs​
-
BS, Microbiology: Queen’s University Belfast
Robert Hussa, PhD
Director, VP Project Management
-
Adeza Biomedical (Cytyc/Hologic)
-
VP R&D
-
-
Eli Lilly & Company/Hybritech​
-
VP R&D​​
-
-
Medical College of Wisconsin
- ​Professor of OB/Gyn and Biochemistry
- Indiana University at Indianapolis​
​
Authored over 100 publications
Ph.D, Biochemistry & Biophysics: Univ of Hawaii
BS, Chemistry: U. Wisconsin - Madison
Terry M. Ryusaki, MT(ASCP)
Chief Commercial Officer
-
CYBIOS Stem Cells
-
CEO
-
-
​Morphogen Stem Cells
-
​President & COO
-
-
​Vitagen/Vital Therapies
-
VP Bus Dev & Mkg​
-
-
Aprogenex​, Inc.
-
VP Sales, Marketing & BD
-
-
Baxter, Stratus Immunochemistry
-
Director Mktg & Customer Ops
-
-
Children's Hospital Los Angeles
-
Medical Technologist​
-
MBA: University of Southern California
BS, Medical Technology: Univ of Hawaii
BA, Microbiology: Univ of Hawaii
Licensed Clinical Lab Scientist:
California MTA 28616
​